Trial intelligence / Profile preview

Special Drug Use Surveillance of Takecab (vonoprazan) for Long-term Maintenance Therapy of Reflux Esophagitis

jRCT1080223147Completed

Sponsor
Takeda
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of vonoprazan in erosive esophagitis (EE), sponsored by Takeda. Started Mar 2016; status: completed.

02

Drugs

vonoprazan
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on jRCT1080223147.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080223147.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call